top of page

Previewing Sunday (Day 2) of the ASH Annual Meeting with ApexOnco's Madeleine Armstrong

Madeleine Armstrong shares her thoughts on CAR-T data in lupus, the menin inhibitor class, BCMA CAR-T, and Regeneron's bi-specific antibody programs.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page